Global Fungal Disease Surveillance and Capacity Funding Opportunity

NOFO: CK21-2106

Related Pages
What’s New?

The Mycotic Diseases Branch Notice of Funding Opportunity (NOFO) CK21-2106: Global Fungal Disease Surveillance and Capacity was used to award over $1.51M in funding to seven cooperative agreement partners working across 11 different countries. Congratulations to:

  • ICDDR, Bangladesh
  • London School of Hygiene and Tropical Medicine
  • Instituto Nacional del Salud
  • Universidad Peruana Cayetano Heredia
  • College of Medicine, University of Lagos
  • WITS Health Consortium
  • Integral Global Consulting

These partners will be working on a wide range of activities, including surveillance, capacity-building, professional development, and education and awareness. Mycoses addressed through this cooperative agreement include antimicrobial-resistant fungal species, invasive mold infections, and healthcare- and HIV-associated fungal infections.

The purpose of this Notice of Funding Opportunity (NOFO) is to reduce illness and death due to fungal diseases around the world caused by both known and emerging pathogens. This internationally focused NOFO supports CDC’s strategic priorities to prevent the spread of infectious diseases.

Globally, fungal diseases pose a significant public health threat, and can be:

  • Opportunistic, meaning they affect people with weakened immune systems—for example, people living with HIV.
  • Acquired in the community or in healthcare settings.
  • Resistant to antifungal drugs, making treatment challenging.

Download information from the Global NOFO Webinar:

CDC’s Mycotic Diseases Branch works throughout the world to prevent and control fungal infections. This includes improving diagnosis and treatment of cryptococcal meningitis and histoplasmosis, especially in people living with HIV, and responding to emerging fungal diseases such as Candida auris, which causes severe illness in hospitalized patients.

This NOFO prioritizes:

Millions of fungal diseases around the world
  1. Increasing surveillance for fungal diseases and outbreaks by building epidemiology, laboratory, and bioinformatics capacity
  2. Increasing support for identifying and responding to known, reemerging, and new fungal pathogens
  3. Engaging and training frontline personnel and broader workforce in CDC best practices to support the prevention and control of fungal diseases
  4. Targeting guidance and tools to:
    1. Better reach communities and populations at increased risk for fungal diseases
    2. Reduce fungal disease spread in healthcare facilities or high-risk settings
  5. Monitoring and evaluating the impact and effectiveness of strategies for improved fungal infection prevention and control practices
  6. Assessing and refining performance metrics for:
    1. Fungal infection control and prevention practices
    2. Outbreak data
    3. Fungal identification strategies
    4. Antifungal resistant specimens
    5. Strain-typing strategies (e.g., whole genome sequencing)

How to Apply

This NOFO opened May 28, 2021, and closed July 27, 2021, on Grants.govexternal icon. More information about future announcements related to this NOFO, and how to apply in future years, will be provided in the coming months on Grants.gov.

For questions about the NOFO, please email MDBCoAg@cdc.gov
Page last reviewed: November 1, 2021
Content source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED)